March 10, 2026

Disclaimer: The information provided here is for educational purposes only and is not intended as medical advice. It should not be used to diagnose, treat, cure, or prevent any medical condition. Instead, use it as a starting point for discussion with your healthcare provider. Always consult with a qualified healthcare provider before starting any new medication, supplement, device, or making changes to your health regimen.
For someone living with complex chronic illness, a headache is rarely just a headache. It is often an invisible, relentless companion that dictates every aspect of daily life, from the moment you wake up to the moment you try to sleep. If you are battling Long COVID, Postural Orthostatic Tachycardia Syndrome (POTS), Mast Cell Activation Syndrome (MCAS), or hypermobile Ehlers-Danlos Syndrome (hEDS), you may have been told by well-meaning friends or even medical professionals to simply "take an ibuprofen and rest." Yet, for those suffering from chronic daily headaches, orthostatic headaches, or histamine-triggered migraines, these standard suggestions are not only unhelpful—they can feel profoundly dismissive of a very real, measurable, and debilitating neurological reality.
The truth is that the headaches associated with these interconnected conditions are fundamentally different from typical tension headaches. They are driven by complex biological mechanisms, including severe neuroinflammation, cerebral hypoperfusion (lack of blood flow to the brain), and hyperactive immune responses in the protective linings of the brain. Whether you are experiencing the sudden, unyielding onset of new daily persistent headache (NDPH) following a COVID-19 infection, or the crushing pressure of an orthostatic headache every time you stand up, your pain is valid and rooted in physiological dysfunction. Understanding the specific biological drivers behind your head pain is the first critical step toward finding effective, targeted management strategies that go beyond over-the-counter painkillers.
More Than Just a Bad Day
When most people think of a headache, they imagine a temporary inconvenience caused by stress, dehydration, or a lack of sleep. However, in the context of complex chronic conditions, a headache is a profound neurological event that often signals systemic distress. For individuals with Long COVID, POTS, or MCAS, head pain is frequently chronic, meaning it occurs on 15 or more days per month, and often daily. This relentless pain is not a psychological manifestation of anxiety or stress; it is a direct result of measurable physiological abnormalities, such as altered blood flow, immune system overactivation, and structural instability in the cervical spine.
One of the most defining characteristics of chronic headaches in this patient population is their resistance to standard treatments. Traditional abortive medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or triptans, frequently fail to provide relief because they do not address the underlying mechanisms driving the pain. In some cases, such as with MCAS, certain NSAIDs can actually trigger further mast cell degranulation, inadvertently worsening the headache. This treatment resistance can lead to a frustrating cycle of seeking help, trying new medications, and experiencing no relief, leaving patients feeling hopeless and isolated.
The Spectrum of Chronic Headaches
The term "headache" in chronic illness is actually an umbrella term that encompasses several distinct, severe pain phenotypes. One of the most common presentations in Long COVID is new daily persistent headache (NDPH), a rare primary headache disorder characterized by its abrupt and highly memorable onset. Patients can often recall the exact day, and sometimes the exact hour, their headache began, and from that moment on, the pain is unremitting. NDPH is notoriously difficult to treat and is frequently accompanied by a constellation of neuropsychological symptoms, including severe brain fog, sleep disturbances, and persistent fatigue.
Another major phenotype is the orthostatic headache, which is intimately linked to dysautonomia and conditions like POTS. An orthostatic headache is uniquely positional; it becomes significantly worse when the patient is standing or sitting upright and improves, sometimes completely, when the patient lies flat. This type of headache is a direct consequence of gravity interacting with a dysfunctional autonomic nervous system or structural vulnerabilities, leading to a lack of adequate blood flow or cerebrospinal fluid pressure in the brain. Understanding which specific type of headache you are experiencing is crucial, as the management strategies for NDPH, orthostatic headaches, and histamine-driven migraines are vastly different.
Viral Invasion and Neuroinflammation
To understand why Long COVID causes such severe and persistent head pain, we must look at how the SARS-CoV-2 virus interacts with the central nervous system. Research suggests that the virus can directly invade or irritate the endings of the trigeminal nerve in the nasal cavity, which is the brain's primary pain-signaling pathway for headaches. This invasion triggers an overstimulation of the trigeminovascular system, setting off a cascade of neuroinflammation. According to studies on Long COVID headaches, this localized neuro-inflammation may act as the physical catalyst for a headache that never turns off, explaining the high prevalence of NDPH in post-COVID patients.
Furthermore, NDPH is largely hypothesized to be driven by chronic, systemic immune activation. The sustained production of pro-inflammatory cytokines and the persistent activation of glial cells—the immune cells of the central nervous system—keep the brain in a chronic state of pain. This persistent neuroinflammation is compounded by endothelial dysfunction, where the virus damages the cells lining the blood vessels. The resulting microvascular issues and hypercoagulability (micro-clots) can continuously deprive neurological tissues of adequate oxygen, a condition known as hypoxemia, which further exacerbates the unyielding head pain.
Cerebral Blood Flow and the Upright Brain
In patients with POTS, the biology of an orthostatic headache is heavily tied to cerebral hemodynamics. When a healthy person stands up, their autonomic nervous system instantly adjusts blood vessel tone to ensure a steady supply of blood to the brain. In POTS, this autoregulation fails. As blood pools in the lower extremities, the brain experiences cerebral hypoperfusion, a significant reduction in blood flow and oxygen delivery. Recent research using Doppler ultrasound has shown that abnormal reductions in cerebral blood flow occur in nearly all patients with POTS during tilt-table testing, directly correlating with the severity of their orthostatic headaches.
This hypoperfusion is often worsened by a phenomenon known as hypocapnia. When standing, many POTS patients unknowingly hyperventilate, which drops the carbon dioxide (CO2) levels in their blood. Because CO2 is a powerful vasodilator, its absence causes cerebral blood vessels to constrict, severely restricting blood flow to the brain even further. This hypocapnia-induced vasoconstriction is a primary driver of the throbbing, pressure-like pain that POTS patients experience when upright. To learn more about how the autonomic nervous system reacts to standing, you can read our guide on Heart Rate Spikes in POTS.
Mast Cells, Histamine, and the Meninges
For patients with MCAS, the biology of migraines is rooted in the immune system, specifically the mast cells that reside in the meninges (the protective membranes surrounding the brain). These dural mast cells are strategically positioned right alongside blood vessels and trigeminal nerve endings. When an MCAS trigger causes these mast cells to degranulate, they release a flood of histamine and other inflammatory mediators directly into the meninges. Histamine is a potent vasodilator that causes local blood vessels to rapidly dilate and become inflamed, while simultaneously lowering the pain threshold of the trigeminal nerve endings.
Once irritated by histamine, the trigeminal nerve fires pain signals into the brainstem, which is experienced as a severe, throbbing migraine. In response, the nerve endings release highly potent neuropeptides, most notably calcitonin gene-related peptide (CGRP). CGRP acts directly back on the mast cells, instructing them to release even more histamine, creating a vicious cycle of sustained neurogenic inflammation. Research into mast cell-driven neuroinflammation highlights that breaking this specific feedback loop is essential for managing MCAS-related migraines, as traditional pain medications cannot stop the ongoing release of immune mediators.
Long COVID and New Daily Persistent Headache (NDPH)
Long COVID has dramatically altered the landscape of chronic headache disorders, bringing NDPH from a relatively rare condition to a widespread phenomenon. According to comprehensive reviews of Long COVID symptoms, around 8% to 22% of patients continue to experience persistent headaches for months after their acute COVID-19 infection clears. These headaches are often described as bilateral, pressing, or burning, and are notoriously resistant to standard migraine therapies. The abrupt onset of these headaches, often perfectly coinciding with the viral infection, highlights the profound impact that systemic viral illnesses can have on the central nervous system's pain pathways.
Patients dealing with Long COVID headaches also frequently experience a cluster of overlapping neurological symptoms. This "neuropsychological spectrum" includes debilitating brain fog, persistent fatigue, and sensory changes like the loss of smell or taste. The interconnected nature of these symptoms suggests a shared underlying mechanism of neuroinflammation and vascular dysfunction. For those looking to support their cellular energy and potentially mitigate some of this fatigue, exploring options like CoQ10 supplementation may be a helpful part of a broader management strategy.
Postural Orthostatic Tachycardia Syndrome (POTS)
In the realm of dysautonomia, POTS is a primary culprit for chronic, debilitating head pain. Orthostatic headaches affect approximately 58% to 66% of all POTS patients, making it one of the most common and limiting manifestations of the disorder. These headaches are directly tied to the patient's posture; the longer a patient remains standing, the more severe the headache becomes due to progressive cerebral hypoperfusion and blood pooling in the lower body. This mechanical and hemodynamic reality makes traditional headache treatments ineffective unless the underlying blood volume and autonomic tone are addressed.
Furthermore, POTS patients often experience a high burden of non-orthostatic migraines as well. The constant fluctuations in cerebral blood flow, combined with the sympathetic nervous system's "fight or flight" overdrive, create an environment highly susceptible to migraine triggers. Patients may also experience accompanying symptoms like visual blurring, neck pain, and nausea when upright. To better understand the cardiovascular symptoms that often accompany these headaches, you can explore our comprehensive guide on Heart Palpitations in Chronic Illness.
Mast Cell Activation Syndrome (MCAS)
MCAS is increasingly recognized as a major driver of chronic, refractory migraines. In a survey of over 500 MCAS patients, participants reported markedly higher prevalences of sensory hypersensitivities and migraines compared to healthy controls. Because mast cells are found throughout the body, including the brain's meninges, their inappropriate activation can cause systemic symptoms that culminate in severe head pain. These histamine-triggered migraines are often accompanied by other MCAS symptoms, such as gastrointestinal distress, skin flushing, and sudden drops in blood pressure.
The clinical presentation of MCAS migraines can be highly unpredictable, as they are tied to a wide array of triggers, including specific foods, environmental allergens, temperature changes, and emotional stress. This unpredictability makes identifying the root cause of the headache incredibly challenging without a deep understanding of mast cell biology. For patients dealing with the systemic inflammation caused by MCAS, foundational nutritional support, such as Omega-3 supplementation, is often utilized to help calm the inflammatory cascade.
Hypermobile Ehlers-Danlos Syndrome (hEDS)
Hypermobile EDS, a genetic connective tissue disorder, introduces profound structural vulnerabilities that lead to complex headache disorders. Because EDS causes defective collagen production, the ligaments supporting the cervical spine are abnormally lax. This laxity can lead to Craniocervical Instability (CCI), where excessive movement of the skull on the spine compresses the brainstem and cranial nerves, resulting in severe cervicogenic headaches. These headaches typically start at the base of the skull and radiate upward, often accompanied by a sensation that the head is "too heavy" for the neck.
Additionally, the fragile connective tissue in EDS extends to the dura mater, the membrane holding in cerebrospinal fluid (CSF). EDS patients are highly susceptible to spontaneous dural tears, leading to CSF leaks and a condition known as Spontaneous Intracranial Hypotension (SIH). The hallmark of a CSF leak is an excruciating orthostatic headache caused by the brain physically sagging inside the skull due to the loss of fluid buoyancy. Diagnosing the root cause of headaches in EDS is notoriously difficult because CCI, CSF leaks, and standard migraines share heavily overlapping symptoms and can even coexist in the same patient.
The Cognitive Toll of Constant Pain
Living with chronic daily headaches fundamentally alters a person's ability to engage with the world. Many patients report that the sheer intensity and persistence of the pain consume an enormous amount of cognitive energy, leaving little bandwidth for anything else. This constant state of pain exacerbates the brain fog and cognitive dysfunction already present in Long COVID, POTS, and MCAS. Tasks that once required minimal effort—such as reading an email, holding a conversation, or remembering a grocery list—can become monumental challenges when your brain is simultaneously processing severe pain signals.
The unpredictability of these headaches also takes a heavy toll on professional and social lives. Because a histamine migraine or an orthostatic headache can strike with little warning, patients often find themselves forced to cancel plans, leave work early, or withdraw from social engagements. This unreliability is not a choice, but a biological necessity to manage the pain. As one patient described, "It feels like my world has shrunk to the size of my bedroom; the pain dictates what I can and cannot do on any given day."
The Upright Trap: Gravity as an Enemy
For those suffering from orthostatic headaches due to POTS or CSF leaks, gravity itself becomes an adversary. The simple act of standing up to cook a meal, take a shower, or wait in line can trigger a cascade of throbbing head pain, dizziness, and nausea. This creates what many patients call the "upright trap"—they cannot stand or sit upright without severe pain due to cerebral hypoperfusion or brain sag, but lying down flat all day leads to severe deconditioning and isolation. This positional dependency makes standard daily activities incredibly difficult to navigate without extensive accommodations.
Furthermore, the invisible nature of orthostatic headaches often leads to misunderstandings with family, friends, and employers. Because the patient may look perfectly healthy while lying down, others may struggle to comprehend why they cannot simply "push through" and sit at a desk or attend a social event. Validating that this inability to remain upright is a structural and hemodynamic failure, not a lack of willpower, is essential for the mental well-being of the patient.
The Emotional Weight of Invisible Illness
The emotional burden of chronic headaches is compounded by the frequent medical gaslighting patients experience. Because standard MRI scans and routine blood work often return "normal" results in cases of POTS, MCAS, and even some cases of Long COVID, patients are frequently told their pain is psychosomatic. Being repeatedly dismissed by medical professionals while suffering from unbearable daily pain leads to profound medical trauma, anxiety, and depression. Research shows that acknowledging the physiological reality of these headaches is one of the most therapeutic interventions a provider can offer, as it restores the patient's trust in their own bodily experiences.
Quantifying the Invisible
When a standard medical appointment is only 15 to 30 minutes long, effectively communicating the severity and frequency of your headaches is crucial. Because pain is subjective and invisible, utilizing validated scales and structured tracking methods can help translate your experience into actionable data for your healthcare provider. Instead of simply stating "I have a headache every day," tracking allows you to present specific patterns, such as "My headache reaches an 8/10 severity within 10 minutes of standing, and is accompanied by a heart rate spike of 40 bpm." This level of detail points directly toward autonomic and hemodynamic dysfunction rather than a standard tension headache.
Patients are encouraged to use comprehensive symptom diaries or digital tracking apps to monitor their pain. Key metrics to record include the exact time of onset, the character of the pain (e.g., throbbing, burning, pressure), the location (e.g., base of the skull, behind the eyes), and any accompanying symptoms like nausea, visual changes, or brain fog. Additionally, tracking the duration of the headache and its response to any interventions—whether that is lying flat, taking an antihistamine, or drinking electrolytes—provides vital clues for your medical team to determine the underlying mechanism.
Tracking Orthostatic and Postural Triggers
For those suspecting POTS or a CSF leak, tracking the relationship between posture and pain is essential. A highly effective way to measure this at home is by performing a modified NASA Lean Test or simply recording orthostatic vitals. This involves measuring your heart rate and blood pressure while lying flat for 10 minutes, and then recording those same metrics every 2 minutes after standing up for a total of 10 minutes. Crucially, you should also record the exact minute your headache begins or worsens during this standing period.
Documenting the "time to symptom onset" while upright helps differentiate between different types of orthostatic intolerance. For example, if your headache begins immediately upon standing and is accompanied by a massive heart rate spike, it strongly suggests POTS and cerebral hypoperfusion. If the headache develops more slowly over several hours of being upright and is relieved entirely by lying flat, it may point toward a CSF leak. Sharing these specific postural correlations with your neurologist or autonomic specialist can significantly expedite an accurate diagnosis.
Identifying Hidden Dietary and Environmental Triggers
If MCAS is a suspected driver of your chronic migraines, tracking dietary and environmental triggers becomes a primary investigative tool. Histamine levels in food can vary wildly depending on how the food is prepared, stored, and aged. Patients should keep a detailed food diary, noting not just what they ate, but how fresh it was and how it was cooked. For instance, eating freshly cooked chicken might cause no symptoms, while eating that same chicken as leftovers the next day (when histamine levels have multiplied) might trigger a severe migraine.
In addition to food, it is important to track environmental and physiological triggers. Note any exposure to strong odors, temperature extremes, mold, or pollen, as well as your current stress levels and menstrual cycle phase. Because mast cell degranulation is cumulative—often referred to as the "histamine bucket" theory—a migraine may not be caused by a single trigger, but rather the overflowing of your total inflammatory load. By meticulously tracking these variables, you and your provider can begin to identify patterns and implement targeted avoidance strategies.
Hydration and Hemodynamic Support
For patients whose headaches are driven by POTS and cerebral hypoperfusion, aggressive hydration and blood volume expansion are foundational management strategies. The standard clinical recommendation for POTS patients is to consume 2 to 3 liters of water per day, paired with 3 to 5 grams of sodium to help the body retain that fluid and expand blood volume. This increased blood volume helps ensure that more blood reaches the brain when standing, directly combating the hypocapnia and vasoconstriction that trigger orthostatic headaches. Many patients find that starting their day with a large dose of electrolytes before even getting out of bed can significantly reduce the severity of their morning head pain.
In addition to oral hydration, physical counter-maneuvers and compression garments play a vital role in hemodynamic support. Medical-grade lower-body compression garments (such as waist-high compression tights or abdominal binders) physically prevent blood from pooling in the legs and abdomen. By forcing blood back up toward the heart and brain, these garments can dramatically improve orthostatic tolerance and reduce headache frequency. For those looking for targeted nutritional support to aid in circulation and vascular health, exploring options like Vessel Forte™ may provide additional benefits alongside standard hydration protocols.
Dietary Modifications for Mast Cell Stability
When chronic migraines are driven by MCAS, dietary intervention is a critical component of breaking the neuro-inflammatory cycle. A strict low-histamine diet is often recommended to reduce the overall burden of histamine in the bloodstream, thereby lowering the likelihood of mast cells in the meninges triggering a migraine. This involves avoiding fermented foods, aged cheeses, cured meats, alcohol, and certain histamine-liberating fruits like citrus and tomatoes. Because histamine accumulates rapidly in protein-rich foods, patients must also prioritize eating fresh, same-day meals and immediately freezing any leftovers.
Beyond avoiding histamine, stabilizing blood sugar is also important for managing chronic headaches, particularly in the context of dysautonomia. Digesting large, heavy meals—especially those high in simple carbohydrates—forces a significant amount of blood to pool in the splanchnic (gut) region. This "postprandial hyperemia" starves the brain of blood, frequently triggering orthostatic headaches and tachycardia in POTS patients. Transitioning to smaller, more frequent, low-glycemic meals can help maintain steady blood flow to the brain and prevent these post-meal symptom flares.
Targeted Medication Protocols
Treating chronic daily headaches in complex illness requires specialized pharmacological approaches, as standard pain relievers often fail. For MCAS-driven migraines, the first line of defense is blocking histamine receptors. A common protocol involves combining H1 blockers (like cetirizine or fexofenadine) with H2 blockers (like famotidine) to stop histamine from binding to nerve endings and causing inflammation. If antihistamines are insufficient, specialists may introduce mast cell stabilizers, such as oral cromolyn sodium or ketotifen, which work to prevent the mast cells from releasing their inflammatory mediators in the first place.
For POTS-related headaches, medications that stabilize the autonomic nervous system are utilized. Beta-blockers or heart-rate lowering agents like ivabradine can help blunt the orthostatic tachycardia, while medications like midodrine or fludrocortisone are used to constrict blood vessels and expand blood volume. However, neurologists note that fludrocortisone can sometimes trigger or worsen headaches in certain patients, so its use must be monitored closely. For post-COVID chronic migraines, modern CGRP inhibitors (such as Nurtec or Qulipta) have shown significant efficacy. By blocking the CGRP neuropeptide, these medications successfully disrupt the communication between the trigeminal nerve and dural mast cells, breaking the cycle of neurogenic inflammation.
Neuromodulation and Structural Support
Non-pharmacological interventions are increasingly recognized as essential tools for managing refractory headaches. Vagus Nerve Stimulation (VNS), using non-invasive devices like gammaCore, is highly recommended for both migraines and POTS. The vagus nerve controls parasympathetic output, and stimulating it can effectively reduce sympathetic "fight or flight" overdrive and lower pro-inflammatory cytokines, providing relief without the side effects of systemic medications. Additionally, for patients with Long COVID and ME/CFS, strict "pacing" is foundational. Overexertion triggers Post-Exertional Malaise (PEM), which often manifests as a severe, multi-day headache crash. Learning to stay within your energy envelope is a critical preventative strategy.
For patients with hEDS suffering from cervicogenic headaches due to Craniocervical Instability (CCI), structural support is paramount. Conservative management involves specialized physical therapy tailored for hypermobility, focusing on isometric neck strengthening to support the lax ligaments. Rigid cervical bracing may also be used to temporarily stabilize the skull and relieve brainstem compression. In severe cases where conservative measures fail and neurological deficits are profound, surgical interventions like Occipitocervical Fusion (OCF) may be necessary to permanently stabilize the joint and resolve the debilitating head pain.
Validating Your Experience
If you are living with chronic daily headaches, orthostatic head pain, or relentless migraines alongside Long COVID, POTS, MCAS, or hEDS, please know that your pain is real, measurable, and valid. You are not exaggerating your symptoms, and your inability to "push through" the pain is a reflection of profound biological and structural challenges, not a lack of resilience. The medical community is rapidly expanding its understanding of how viral infections, autonomic dysfunction, and immune hyperreactivity intersect to create these complex headache disorders. There is growing recognition that traditional treatments are often inadequate for this specific patient population, paving the way for more targeted, effective therapies.
Building a Comprehensive Care Team
Managing chronic headaches in the context of complex multisystem illness requires a collaborative and highly specialized approach. Because these headaches are driven by overlapping mechanisms—ranging from cerebral hypoperfusion to mast cell degranulation—a single specialist is rarely enough. Building a care team that understands the intricate connections between neurology, immunology, and autonomic function is essential. By tracking your symptoms meticulously and advocating for treatments that address the root biological causes, you can begin to break the cycle of neuroinflammation and regain a better quality of life.
Taking the Next Step
Navigating the complexities of Long COVID, dysautonomia, and mast cell disorders can be overwhelming, but you do not have to do it alone. At RTHM, we are dedicated to providing comprehensive, science-backed care for individuals living with these challenging conditions. If you are looking for targeted nutritional support to complement your management strategies, we invite you to Explore RTHM's supplement options. Always remember to consult with your primary healthcare provider or a qualified specialist before starting or stopping any new treatments, medications, or supplements to ensure they are safe and appropriate for your specific medical needs.
Frontiers in Neurology. (2023). "Evaluation and management of orthostatic headache in hypermobility disorders." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10755355/
Journal of the American Heart Association. (2024). "Cerebral Blood Flow in Orthostatic Intolerance." https://www.ahajournals.org/doi/10.1161/JAHA.123.033504
Mast Cell Action. (2025). "Prevalence and treatment response of neuropsychiatric disorders in mast cell activation syndrome." https://www.mastcellaction.org/assets/_/2025/07/14/61f9dbdc-d26d-4f38-9e20-58eb1c88dca5/neuropsychiatric-prevalence.pdf?v=1
Current Pain and Headache Reports. (2023). "Dysautonomia, Hypermobility Spectrum Disorders and Mast Cell Activation Syndrome as Migraine Comorbidities." https://pubmed.ncbi.nlm.nih.gov/37847487/
The Journal of Headache and Pain. (2021). "New daily persistent headache: a systematic review on an enigmatic primary headache disorder." https://pubmed.ncbi.nlm.nih.gov/34914165/
Frontiers in Neurology. (2024). "Orthostatic intolerance with tachycardia (POTS) and without (HYCH) represent a spectrum of the same disorder." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11562747/
MDPI. (2020). "Orthostatic Headache in Children Including Postural Tachycardia Syndrome and Orthostatic Hypotension: A Near-Infrared Spectroscopy Study." https://www.mdpi.com/1660-4601/17/24/9566
Nature Medicine. (2021). "Post-acute COVID-19 syndrome." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459926/